<DOC>
	<DOC>NCT01075945</DOC>
	<brief_summary>Dihydroartemisinin- Piperaquine is not inferior to artemether-lumefantrine</brief_summary>
	<brief_title>Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria, Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<criteria>Uncomplicated malaria Severe cases Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>antimalarials</keyword>
	<keyword>ACTs</keyword>
	<keyword>Piperaquine</keyword>
	<keyword>uncomplicated</keyword>
</DOC>